IRIX
Price
$0.93
Change
-$0.10 (-9.71%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
48.42M
34 days until earnings call
MDXH
Price
$1.50
Change
-$0.00 (-0.00%)
Updated
Apr 3, 04:53 PM (EDT)
Capitalization
70.68M
40 days until earnings call
Ad is loading...

IRIX vs MDXH

Header iconIRIX vs MDXH Comparison
Open Charts IRIX vs MDXHBanner chart's image
IRIDEX
Price$0.93
Change-$0.10 (-9.71%)
Volume$1.62K
Capitalization48.42M
MDxHealth SA
Price$1.50
Change-$0.00 (-0.00%)
Volume$209
Capitalization70.68M
IRIX vs MDXH Comparison Chart
Loading...
IRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDXH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IRIX vs. MDXH commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRIX is a StrongBuy and MDXH is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (IRIX: $0.93 vs. MDXH: $1.50)
Brand notoriety: IRIX and MDXH are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: IRIX: 148% vs. MDXH: 97%
Market capitalization -- IRIX: $48.42M vs. MDXH: $70.68M
IRIX [@Medical Specialties] is valued at $48.42M. MDXH’s [@Medical Specialties] market capitalization is $70.68M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IRIX’s FA Score shows that 1 FA rating(s) are green whileMDXH’s FA Score has 0 green FA rating(s).

  • IRIX’s FA Score: 1 green, 4 red.
  • MDXH’s FA Score: 0 green, 5 red.
According to our system of comparison, both IRIX and MDXH are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IRIX’s TA Score shows that 6 TA indicator(s) are bullish while MDXH’s TA Score has 5 bullish TA indicator(s).

  • IRIX’s TA Score: 6 bullish, 2 bearish.
  • MDXH’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, IRIX is a better buy in the short-term than MDXH.

Price Growth

IRIX (@Medical Specialties) experienced а +5.32% price change this week, while MDXH (@Medical Specialties) price change was -1.32% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.68%. For the same industry, the average monthly price growth was +1.30%, and the average quarterly price growth was +1.15%.

Reported Earning Dates

IRIX is expected to report earnings on May 08, 2025.

MDXH is expected to report earnings on May 14, 2025.

Industries' Descriptions

@Medical Specialties (-4.68% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MDXH($70.7M) has a higher market cap than IRIX($48.4M). MDXH YTD gains are higher at: -36.709 vs. IRIX (-38.690). IRIX has higher annual earnings (EBITDA): -6.79M vs. MDXH (-26.16M). MDXH has more cash in the bank: 32.7M vs. IRIX (9.82M). IRIX has less debt than MDXH: IRIX (1.26M) vs MDXH (40.7M). MDXH has higher revenues than IRIX: MDXH (63.7M) vs IRIX (56.4M).
IRIXMDXHIRIX / MDXH
Capitalization48.4M70.7M68%
EBITDA-6.79M-26.16M26%
Gain YTD-38.690-36.709105%
P/E RatioN/AN/A-
Revenue56.4M63.7M89%
Total Cash9.82M32.7M30%
Total Debt1.26M40.7M3%
FUNDAMENTALS RATINGS
IRIX vs MDXH: Fundamental Ratings
IRIX
MDXH
OUTLOOK RATING
1..100
771
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
43
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
9389
P/E GROWTH RATING
1..100
1100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MDXH's Valuation (43) in the null industry is somewhat better than the same rating for IRIX (91) in the Medical Specialties industry. This means that MDXH’s stock grew somewhat faster than IRIX’s over the last 12 months.

MDXH's Profit vs Risk Rating (100) in the null industry is in the same range as IRIX (100) in the Medical Specialties industry. This means that MDXH’s stock grew similarly to IRIX’s over the last 12 months.

IRIX's SMR Rating (99) in the Medical Specialties industry is in the same range as MDXH (100) in the null industry. This means that IRIX’s stock grew similarly to MDXH’s over the last 12 months.

MDXH's Price Growth Rating (89) in the null industry is in the same range as IRIX (93) in the Medical Specialties industry. This means that MDXH’s stock grew similarly to IRIX’s over the last 12 months.

IRIX's P/E Growth Rating (1) in the Medical Specialties industry is significantly better than the same rating for MDXH (100) in the null industry. This means that IRIX’s stock grew significantly faster than MDXH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IRIXMDXH
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
63%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
58%
Momentum
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
65%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
64%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
71%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
56%
Advances
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
72%
Declines
ODDS (%)
Bearish Trend 10 days ago
81%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
71%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
54%
View a ticker or compare two or three
Ad is loading...
IRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDXH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALGS7.580.44
+6.16%
Aligos Therapeutics Inc
LEGN33.241.72
+5.46%
Legend Biotech Corp
DNA5.960.30
+5.30%
Ginkgo Bioworks Holdings
EXTR13.420.29
+2.21%
Extreme Networks
SAN6.850.07
+1.03%
Banco Santander SA

IRIX and

Correlation & Price change

A.I.dvisor tells us that IRIX and NTRA have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IRIX and NTRA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRIX
1D Price
Change %
IRIX100%
+3.96%
NTRA - IRIX
31%
Poorly correlated
+1.81%
CNTGF - IRIX
28%
Poorly correlated
N/A
MDXH - IRIX
26%
Poorly correlated
+3.09%
SNN - IRIX
26%
Poorly correlated
-0.21%
DRIO - IRIX
26%
Poorly correlated
+6.69%
More

MDXH and

Correlation & Price change

A.I.dvisor tells us that MDXH and MEHCQ have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MDXH and MEHCQ's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDXH
1D Price
Change %
MDXH100%
N/A
MEHCQ - MDXH
28%
Poorly correlated
-16.13%
BNGO - MDXH
28%
Poorly correlated
-10.40%
DCTH - MDXH
27%
Poorly correlated
-7.63%
IRIX - MDXH
27%
Poorly correlated
-9.71%
MYO - MDXH
25%
Poorly correlated
-4.29%
More